Abbreviations GLP-1 Glucagon Like Peptide-1 CV Cardio Vascular DPP-4 DiPeptidylPeptidase-4 USFDA United States Food & Drug Administration Aib 2-Aminoisobutyric acid SNAC Sodium-N-[8-(2-hydroxybenzoyl)amino]caprylate SUSTAIN Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes FPG Fasting Plasma Glucose HOMA-B Homeostasis model assessment of -cell function ER Extended release DXA Dual energy X-ray Absorptiometry OAD Oral Antidiabetic Drugs SGLT-2 Sodium GLucose co-Transporter-2 SMBG Self-Monitoring of Blood Glucose PIONEER Peptide Innovation for Early Diabetes Treatment EMA European Medicines Agency Authors contributions Conceptualization: Manoj Kumar Mahapatra
Potential side effects include local skin irritation, contact dermatitis, and theoretical drug interactions if systemic absorption occurs
Additionally, persistent nausea, which occurs in up to 44% of patients taking Wegovy at the 2.4 mg maintenance dose, can create a generally unpleasant oral sensation that patients may describe as a bad taste
However, keep in mind that seizures may limit the type of calorie-burning exercises you can do
1k, l) and presence in the membrane fraction (Fig
(5.8) Adverse Reactions/Side Effects Most common adverse reactions associated with empagliflozin (5% or greater incidence) were urinary tract infections and female genital mycotic infections
